Kupffer cells are activated in cirrhotic portal hypertension and not normalised by TIPS

Gut

Volumn 60, Issue 10, 2011, Pages 1389-1393

  Holland Fischer, Peter ^a   Grønbæk, Henning ^a   Sandahl, Thomas Damgaard ^a   Moestrup, Søren K ^a,b   Riggio, Oliviero ^c   Ridola, Lorenzo ^c   Aagaard, Niels Kristian ^a   Møller, Holger Jon ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIGEN; GALACTOSE; LIPOPOLYSACCHARIDE BINDING PROTEIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTOXEMIA; FEMALE; FOLLOW UP; HEPATIC VEIN; HUMAN; KUPFFER CELL; LIPOPOLYSACCHARIDE BINDING PROTEIN BLOOD LEVEL; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PORTAL HYPERTENSION; PORTAL VEIN; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; SOLUBLE CD163 BLOOD LEVEL; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ADULT; AGED; ANTIGENS, CD; FEMALE; HUMANS; HYPERTENSION, PORTAL; IMMUNITY, CELLULAR; KUPFFER CELLS; LIVER CIRRHOSIS; MACROPHAGE ACTIVATION; MALE; MIDDLE AGED; PLATELET MEMBRANE GLYCOPROTEINS; PORTAL PRESSURE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RECOVERY OF FUNCTION;

EID: 80052555431     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2010.234542     Document Type: Article

References (39)

1. Shah V.H., Kamath P.S. Portal hypertension and gastrointestinal bleeding. In: Feldman M, Friedman LS, Brandt LJ, eds. Feldman: Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th edn. Philadelphia, PA: Saunders Elsevier, 2006:1899-1927
2. Moller H.J., Gronbaek H., Schiodt F.V., et al. Soluble CD163 from activated macrophages predicts mortality in acute liver failure. J Hepatol 2007;47:671-676 (Pubitemid 47503425)
3. Graupera M., Garcia-Pagan J.C., Titos E., et al. 5-Lipoxygenase inhibition reduces intrahepatic vascular resistance of cirrhotic rat livers: A possible role of cysteinylleukotrienes. Gastroenterology 2002;122:387-393 (Pubitemid 34116990)
4. Steib C.J., Gerbes A.L., Bystron M., et al. Kupffer cell activation in normal and fibrotic livers increases portal pressure via thromboxane A(2). J Hepatol 2007;47:228-238 (Pubitemid 47021253)
5. Yokoyama Y., Xu H., Kresge N., et al. Role of thromboxane A2 in early BDL-induced portal hypertension. Am J Physiol Gastrointest Liver Physiol 2003;284:G453-G460 (Pubitemid 36227893)
6. Wake K., Decker K., Kirn A., et al. Cell biology and kinetics of Kupffer cells in the liver. Int Rev Cytol 1989;118:173-229. (Pubitemid 20040541)
7. Hiraoka A., Horiike N., Akbar S.M., et al. Expression of CD163 in the liver of patients with viral hepatitis. Pathol Res Pract 2005;201:379-384 (Pubitemid 40862463)
8. Liu Z.X., Kaplowitz N. Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2006;2:493-503. (Pubitemid 46118323)
9. Rolando N., Wade J., Davalos M., et al. The systemic inflammatory response syndrome in acute liver failure. Hepatology 2000;32:734-739
10. Bautista A.P. Impact of alcohol on the ability of Kupffer cells to produce chemokines and its role in alcoholic liver disease. J Gastroenterol Hepatol 2000;15:349-356 (Pubitemid 30262200)
11. Kristiansen M., Graversen J.H., Jacobsen C., et al. Identification of the haemoglobin scavenger receptor. Nature 2001;409:198-201. (Pubitemid 32144285)
12. Moller HJ, de FM, Aerts H, et al. Plasma level of the macrophage-derived soluble CD163 is increased and positively correlates with severity in Gaucher's disease. Eur J Haematol 2004;72:135-139
13. Schaer D.J., Schleiffenbaum B., Kurrer M., et al. Soluble hemoglobinehaptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. Eur J Haematol 2005;74:6-10. (Pubitemid 40143680)
14. Weaver L.K., Hintz-Goldstein K.A., Pioli P.A., et al. Pivotal advance: Activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 2006;80:26-35. (Pubitemid 44835523)
15. Moestrup S.K., Moller H.J. CD163: A regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response. Ann Med 2004;36:347-354 (Pubitemid 39233102)
16. Goulis J., Patch D., Burroughs A.K. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999;353:139-142 (Pubitemid 29088094)
17. De Franchis R. Evolving consensus in portal hypertension. Report of the Baveno IV consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-176 (Pubitemid 40805288)
18. Rossle M., Haag K., Ochs A., et al. The transjugular intrahepatic portosystemic stentshunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171 (Pubitemid 24026884)
19. Tygstrup N. Determination of the hepatic elimination capacity (Lm) of galactose by single injection. Scand J Clin Lab Invest Suppl 1966;18:118-125
20. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001;33:464-470 (Pubitemid 32119037)
21. Moller H.J., Hald K., Moestrup S.K. Characterization of an enzyme-linked immunosorbent assay for soluble CD163. Scand J Clin Lab Invest 2002;62:293-299
22. Maniecki M.B., Moller H.J., Moestrup S.K., et al. CD163 positive subsets of blood dendritic cells: The scavenging macrophage receptors CD163 and CD91 are coexpressed on human dendritic cells and monocytes. Immunobiology 2006;211:407-417
23. Klein A., Zhadkewich M., Margolick J., et al. Quantitative discrimination of hepatic reticuloendothelial clearance and phagocytic killing. J Leukoc Biol 1994;55:248-252 (Pubitemid 24066350)
24. Wilmer A., Nolchen B., Tilg H., et al. Serum neopterin concentrations in chronic liver disease. Gut 1995;37:108-112
25. Bhathal P.S., Grossman H.J. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators. J Hepatol 1985;1:325-337 (Pubitemid 15044203)
26. Reichen J., Le M. Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver. J Clin Invest 1986;78:448-455 (Pubitemid 16074082)
27. Etzerodt A., Maniecki M.B., Moller K., et al. Tumor necrosis factor a-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163. J Leukoc Biol 2010;88:1201-1205
28. Bautista A.P., Spolarics Z., Jaeschke H., et al. Antineutrophil monoclonal antibody (1F12) alters superoxide anion release by neutrophils and Kupffer cells. J Leukoc Biol 1994;55:328-335 (Pubitemid 24097238)
29. Philippidis P., Mason J.C., Evans B.J., et al. Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004;94:119-126 (Pubitemid 38064106)
30. Kaser A., Ludwiczek O., Waldenberger P., et al. Endotoxin and its binding proteins in chronic liver disease: The effect of transjugular intrahepatic portosystemic shunting. Liver 2002;22:380-387 (Pubitemid 35331398)
31. Albillos A, de la HA, Gonzalez M, et al. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement. Hepatology 2003;37:208-217
32. Schumann R.R., Kirschning C.J., Unbehaun A., et al. The lipopolysaccharide-binding protein is a secretory class 1 acute-phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 1996;16:3490-3503 (Pubitemid 26199868)
33. Bleichner G., Boulanger R., Squara P., et al. Frequency of infections in cirrhotic patients presenting with acute gastrointestinal haemorrhage. Br J Surg 1986;73:724-726 (Pubitemid 16011175)
34. Ruiz-del-Arbol L., Urman J., Fernandez J., et al. Systemic, renal, and hepatic hemodynamic derangement in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology 2003;38:1210-1218 (Pubitemid 37314829)
35. Hsieh W.J., Lin H.C., Hwang S.J., et al. The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol 1998;93:962-966
36. Rimola A., Bory F., Teres J., et al. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985;5:463-467 (Pubitemid 15065955)
37. Soriano G., Guarner C., Tomas A., et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992;103:1267-1272
38. Miller A.M., Masrorpour M., Klaus C., et al. LPS exacerbates endothelin-1 induced activation of cytosolic phospholipase A2 and thromboxane A2 production from Kupffer cells of the prefibrotic rat liver. J Hepatol 2007;46:276-285 (Pubitemid 44959165)
39. Xu H., Korneszczuk K., Karaa A., et al. Thromboxane A2 from Kupffer cells contributes to the hyperresponsiveness of hepatic portal circulation to endothelin-1 in endotoxemic rats. Am J Physiol Gastrointest Liver Physiol 2005;288:G277-G283 (Pubitemid 40129579)